Разрешен к применению с 1995 года.
Видео о
Купить в
COVID-19 
По алфавиту
H Kirchner, A Körfer, P A Palmer, P Evers, W De Riese, J Knüver-Hopf, M Hadam, U Goldman, C R Franks, H Poliwoda, et al.
Subcutaneous interleukin-2 and interferon-alpha 2b in patients with metastatic renal cell cancer: the German outpatient experienceMol Biother. 1990 Sep;2(3):145-54.
Ha Kim, Byungsuk Kwon, Jeong-Im Sin
Combined stimulation of IL-2 and 4-1BB receptors augments the antitumor activity of E7 DNA vaccines by increasing Ag-specific CTL responsesPLoS One. 2013 Dec 31;8(12):e83765.
Hai-Bo Qiao, Jia Li, Lian-Jie Lv et al. 
PDF
Molecular medicine reports 17: 4853-4859, 2018. DOI: 10.3892/mmr.2018.8408
Han X, Jiang Y, Gu S et al. PDF
Ann Rheum Dis. 2026 Feb;85(2):328-338. doi: 10.1016/j.ard.2025.08.012. Epub 2025 Sep 11. PMID: 40940283.
Hani Choudhry, Nawal Helmi, Wesam H. Abdulaal et al. PDF
Hindawi. BioMed Research International. Vol.2018, Article ID 9056173.
Hanson K.P., Moiseyenko V.M., Orlova R.V. et al.
Efficacy of the chemoimmunotherapy in previously treated patients with malignant metastatic skin melanoma.
10th International congress on anti-cancer treatmentю Paris-France, 2000. P. 117.
Hao Li , Xiang Lin , Jing He
The dual role of IL-2 in systemic lupus erythematosus: balancing pro-inflammatory and anti-inflammatory effects.
Cytokine. 2025 Dec:196:157032. doi: 10.1016/j.cyto.2025.157032. Epub 2025 Sep 18.
Harel-Bellan A, Bertoglio J, Quillet A et al.
Interleukin 2 (IL 2) up-regulates its own receptor on a subset of human unprimed peripheral blood lymphocytes and triggers their proliferation.J Immunol. 1986 Apr 1;136(7):2463-9. PMID: 3005412.
Hernandez R, Põder J, LaPorte KM, Malek TR.
Engineering IL-2 for immunotherapy of autoimmunity and cancer.Nat Rev Immunol. 2022 Oct;22(10):614-628. doi: 10.1038/s41577-022-00680-w. Epub 2022 Feb 25. PMID: 35217787.
Hideaki Miyake, Isao Hara, Iori Sakai, Ken-ichi Harada, Taka-aki Inoue, Hiroshi Eto, Yoshizumi Takechi, Masato Fujisawa
Clinical outcome of combined immunotherapy with low-dose interleukin-2 and interferon-alpha for Japanese patients with metastatic renal cell carcinoma who had undergone radical nephrectomy: a preliminary reportInt J Clin Oncol. 2005 Oct;10(5):338-41.
Hongbin Wang, Mia Borlongan, Akseli Hemminki et al. PDF
Human Gene Therapy. 2023. Vol. 34, No. 17-18.
Hongbo Shi, Wenjing Wang, Jiming Yin tn al. PDF 
ZIP
Cell Death and Disease (2020) 11:429
Horcicka A., Bewersdorf N., Kalkum E. et al. PDF
Effects of preoperative recombinant Interleukin 2-based immunomodulation on outcome after gastrointestinal cancer surgery: a systematic review and meta-analysis.
British Journal of Cancer. — 2026. https://doi.org/10.1038/s41416-025-03304-x
Hosten B, Abbara C, Cibert M et al.
Interleukin-2 treatment effect on imatinib pharmacokinetic, P-gp and BCRP expression in mice.Anticancer Drugs. 2010 Feb;21(2):193-201.
Hosten B., Abbara C., Petit B. et al.
Effect of interleukin-2 pretreatment on paclitaxel absorption and tissue disposition after oral and intravenous administration in mice.Drug Metab Dispos. 2008 Aug;36(8):1729-35. doi: 10.1124/dmd.107.019091. Epub 2008 May 28.
Hotchkiss R.S., Colston E., Yende S. et al. PDF
Immune Checkpoint Inhibition in Sepsis: A Phase 1b Randomized, Placebo-Controlled, Single Ascending Dose Study of Antiprogrammed Cell Death-Ligand 1 (BMS-936559).
Critical Care Medicine. — 2019. — V. XX. — N. XXX. — P. 1-11.
В соответствии с п. 1 ст. 64 Федерального закона от 12.04.2010 № 61-ФЗ "Об обращении лекарственных средств" лекарственные препараты, находящиеся в обращении на территории Российской Федерации, подлежат мониторингу безопасности в целях выявления возможных негативных последствий их применения, предупреждения пациентов и их защиты от применения таких препаратов.